Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

Brigham and Women's Hospital · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
cancer
proteinuric renal disease, proteinuric kidney disease, proteinuria, proteinuria in nephrotic range, vascular endothelial growth factor inhibitors, cancer, endothelin-1 antagonist, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 807390
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.